| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | Jul 7, 2022 | Seres Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +8,738,243 | 59.22% | ✗ | $27.5M |
| Oct 27, 2020 | Oct 29, 2020 | Foghorn Therapeutics Inc. | 10% Owner | Buy | 87.5 | +150,000 | 1.20% | ✗ | $2.4M |